HELENA RUSSELL: Open Payments
NPI 1932855764 · ST AUGUSTINE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,018 in 90 payments from 10 companies in 2025. Trend: 2023 $775 · 2024 $1,424 · 2025 $2,018
Food & beverage: $2,011Education: $7
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 18 | $368 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $308 |
| E.R. Squibb & Sons, L.L.C. | 12 | $297 |
| Teva Pharmaceuticals USA, Inc. | 14 | $266 |
| Janssen Pharmaceuticals, Inc | 5 | $228 |
| Neurocrine BioSciences, Inc. | 10 | $212 |
| Vanda Pharmaceuticals Inc. | 14 | $168 |
| Alkermes, Inc. | 4 | $90 |
| Lundbeck LLC | 2 | $53 |
| Axsome Therapeutics, Inc. | 1 | $29 |
Products named: CAPLYTA, COBENFY, REXULTI, UZEDY, SPRAVATO, INGREZZA, ABILIFY ASIMTUFII, FANAPT.
Industry payments across FL — which companies pay providers there.
